Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
C. Brendan Montano, W. Clay Jackson, Denise Vanacore & Richard Weisler. (2023) Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression. Postgraduate Medicine 135:5, pages 449-465.
Read now
Read now
Rajna Knez, Dejan Stevanovic, Elisabeth Fernell & Christopher Gillberg. (2022) Orexin/Hypocretin System Dysfunction in ESSENCE (Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations). Neuropsychiatric Disease and Treatment 18, pages 2683-2702.
Read now
Read now
Jonathan R. Young, Shayan A. Smani, Nicholas A. Mischel, Michael D. Kritzer, Lawrence G. Appelbaum & Ashwin A. Patkar. (2020) Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature. Journal of Addictive Diseases 38:2, pages 186-199.
Read now
Read now
Tia Sternat, Kathryn Fotinos, Alexa Fine, Irvin Epstein & Martin A Katzman. (2018) Low hedonic tone and attention-deficit hyperactivity disorder: risk factors for treatment resistance in depressed adults. Neuropsychiatric Disease and Treatment 14, pages 2379-2387.
Read now
Read now
Jayarava Attwood. (2018) Defining Vedanā: Through the Looking Glass. Contemporary Buddhism 19:1, pages 31-46.
Read now
Read now
Articles from other publishers (35)
Michael Cronquist Christensen, Michael Adair, Henrik Loft & Roger S. McIntyre. (2023) The Motivation and Energy Inventory (MEI): Analysis of the clinically relevant response threshold in patients with major depressive disorder and emotional blunting using data from the COMPLETE study. Journal of Affective Disorders 323, pages 547-553.
Crossref
Crossref
Miguel Garcia‐Argibay, Ebba Du Rietz, Catharina A. Hartman, Paul Lichtenstein, Zheng Chang, Cristiano Fava, Samuele Cortese & Henrik Larsson. (2022) Cardiovascular risk factors in attention‐deficit/hyperactivity disorder: A family design study of Swedish conscripts. International Journal of Methods in Psychiatric Research 31:4.
Crossref
Crossref
Margus Kanarik, Oliver Grimm, Nina Roth Mota, Andreas Reif & Jaanus Harro. (2022) ADHD co-morbidities: A review of implication of gene × environment effects with dopamine-related genes. Neuroscience & Biobehavioral Reviews 139, pages 104757.
Crossref
Crossref
Lauren E Oddo, Samuel F Acuff, Melanie B Arenson, Assaf Oshri, Andrea Chronis-Tuscano, James MacKillop & James G Murphy. (2022) Unique and Transdiagnostic Dimensions of Reward Functioning in Attention-Deficit/Hyperactivity Disorder and Alcohol Use Disorder Symptoms. Alcohol and Alcoholism 57:4, pages 452-459.
Crossref
Crossref
Keith O. Plowden, Timothy Legg & Dana Wiley. (2022) Attention deficit/hyperactivity disorder in adults: A case study. Archives of Psychiatric Nursing 38, pages 29-35.
Crossref
Crossref
Se-hoon Shim, Young Sup Woo, Ji Sun Kim, In Soo Heo, Hee-jung Yoon, Hyung Mo Sung, Jonghun Lee & Won-Myong Bahk. (2022) Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial. Clinical Psychopharmacology and Neuroscience 20:1, pages 143-153.
Crossref
Crossref
Martin A. Katzman & Matthew P. Katzman. (2022) Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone. Brain Sciences 12:2, pages 150.
Crossref
Crossref
Levent Kirisci & Michael M. Vanyukov. 2022. Genetics of Substance Use. Genetics of Substance Use
3
54
.
Michael Cronquist Christensen, Andrea Fagiolini, Ioana Florea, Henrik Loft, Alessandro Cuomo & Guy M. Goodwin. (2021) Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting. Journal of Affective Disorders 294, pages 924-931.
Crossref
Crossref
Tor-Arne Hegvik, Kai Waløen, Sunil K. Pandey, Stephen V. Faraone, Jan Haavik & Tetyana Zayats. (2019) Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment. Molecular Psychiatry 26:8, pages 4004-4015.
Crossref
Crossref
Vincenza Spera, Alessandro Pallucchini, Marco Carli, Marco Maiello, Angelo Maremmani, Giulio Perugi & Icro Maremmani. (2021) Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture?. Journal of Clinical Medicine 10:7, pages 1481.
Crossref
Crossref
Andrea Fagiolini, Ioana Florea, Henrik Loft & Michael Cronquist Christensen. (2021) Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment. Journal of Affective Disorders 283, pages 472-479.
Crossref
Crossref
Daniel Di Matteo, Wendy Wang, Kathryn Fotinos, Sachinthya Lokuge, Julia Yu, Tia Sternat, Martin A Katzman & Jonathan Rose. (2021) Smartphone-Detected Ambient Speech and Self-Reported Measures of Anxiety and Depression: Exploratory Observational Study. JMIR Formative Research 5:1, pages e22723.
Crossref
Crossref
Shailaja Pokhriyal. 2021. Handbook of Research on Critical Issues in Special Education for School Rehabilitation Practices. Handbook of Research on Critical Issues in Special Education for School Rehabilitation Practices
324
351
.
Amelia D. Serine, Bradley Rosenfield, Robert A. DiTomasso, Jennifer M. Collins, Anthony L. Rostain & J. Russell Ramsay. (2020) The Relationship Between Cognitive Distortions and Adult Attention-Deficit/Hyperactivity Disorder After Accounting for Comorbidities and Personality Traits. Cognitive Therapy and Research 44:5, pages 967-976.
Crossref
Crossref
Jenny Roe, Andrew Mondschein, Chris Neale, Laura Barnes, Medhi Boukhechba & Stephanie Lopez. (2020) The Urban Built Environment, Walking and Mental Health Outcomes Among Older Adults: A Pilot Study. Frontiers in Public Health 8.
Crossref
Crossref
Ji Sun Hong, Sun Mi Kim, Kyoung Doo Kang, Doug Hyun Han, Jeong Soo Kim, Hyunchan Hwang, Kyoung Joon Min, Tae Young Choi & Young Sik Lee. (2020) Effect of physical exercise intervention on mood and frontal alpha asymmetry in internet gaming disorder. Mental Health and Physical Activity 18, pages 100318.
Crossref
Crossref
Stefano Pallanti & Luana SalernoStefano Pallanti & Luana Salerno. 2020. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders
149
165
.
Elisa Brietzke, Emily R. Hawken, Maia Idzikowski, Janice Pong, Sidney H. Kennedy & Claudio N. Soares. (2019) Integrating digital phenotyping in clinical characterization of individuals with mood disorders. Neuroscience & Biobehavioral Reviews 104, pages 223-230.
Crossref
Crossref
Susanne Becker, Anne-Kathrin Bräscher, Scott Bannister, Moustafa Bensafi, Destany Calma-Birling, Raymond C.K. Chan, Tuomas Eerola, Dan-Mikael Ellingsen, Camille Ferdenzi, Jamie L. Hanson, Mateus Joffily, Navdeep K. Lidhar, Leroy J. Lowe, Loren J. Martin, Erica D. Musser, Michael Noll-Hussong, Thomas M. Olino, Rosario Pintos Lobo & Yi Wang. (2019) The role of hedonics in the Human Affectome. Neuroscience & Biobehavioral Reviews 102, pages 221-241.
Crossref
Crossref
Barbara D. Fontana, Francini Franscescon, Denis B. Rosemberg, William H.J. Norton, Allan V. Kalueff & Matthew O. Parker. (2019) Zebrafish models for attention deficit hyperactivity disorder (ADHD). Neuroscience & Biobehavioral Reviews 100, pages 9-18.
Crossref
Crossref
Rui Yan, ShiWan Tao, HaiYan Liu, Yu Chen, JiaBo Shi, YuYin Yang, RongXin Zhu, ZhiJian Yao & Qing Lu. (2019) Abnormal Alterations of Regional Spontaneous Neuronal Activity in Inferior Frontal Orbital Gyrus and Corresponding Brain Circuit Alterations: A Resting-State fMRI Study in Somatic Depression. Frontiers in Psychiatry 10.
Crossref
Crossref
Ciarán M. Fitzpatrick, Annika H. Runegaard, Søren H. Christiansen, Nikolaj W. Hansen, Søren H. Jørgensen, Julia C. McGirr, Amaia de Diego Ajenjo, Andreas T. Sørensen, Jean-François Perrier, Anders Petersen, Ulrik Gether, David P.D. Woldbye & Jesper T. Andreasen. (2019) Differential effects of chemogenetic inhibition of dopamine and norepinephrine neurons in the mouse 5-choice serial reaction time task. Progress in Neuro-Psychopharmacology and Biological Psychiatry 90, pages 264-276.
Crossref
Crossref
Federico Mucci, Maria Teresa Avella & Donatella Marazziti. (2019) ADHD with Comorbid Bipolar Disorders: A Systematic Review of Neurobiological, Clinical and Pharmacological Aspects Across the Lifespan. Current Medicinal Chemistry 26:38, pages 6942-6969.
Crossref
Crossref
Sarah J. BaileyStephen M. Husbands. (2018) Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?. Neuronal Signaling 2:2.
Crossref
Crossref
Stephen V. Faraone. (2018) The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neuroscience & Biobehavioral Reviews 87, pages 255-270.
Crossref
Crossref
G. Guihard. (2018) Exploration of mental health of health students: Dental and medical formations promote anhedonia. L'Encéphale 44:2, pages 94-100.
Crossref
Crossref
Thomas McLaughlin, Kenneth Blum, Bruce Steinberg, Edward J. Modestino, Lyle Fried, David Baron, David Siwicki, Eric R. Braverman & Rajendra D. Badgaiyan. (2018) Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD. Journal of Behavioral Addictions 7:1, pages 192-203.
Crossref
Crossref
Espen Anker, Bothild Bendiksen & Trond Heir. (2018) Comorbid psychiatric disorders in a clinical sample of adults with ADHD, and associations with education, work and social characteristics: a cross-sectional study. BMJ Open 8:3, pages e019700.
Crossref
Crossref
Oloruntoba J Oluboka, Martin A Katzman, Jeffrey Habert, Diane McIntosh, Glenda M MacQueen, Roumen V Milev, Roger S McIntyre & Pierre Blier. (2018) Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient. International Journal of Neuropsychopharmacology 21:2, pages 128-144.
Crossref
Crossref
Troy K. Chow, Sidney Kennedy & Sakina J. Rizvi. 2018. Understanding Depression. Understanding Depression
99
112
.
Martin A. Katzman, Timothy S. Bilkey, Pratap R. Chokka, Angelo Fallu & Larry J Klassen. (2017) Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry 17:1.
Crossref
Crossref
Yi Lu, Zonglin Shen, Yuqi Cheng, Hui Yang, Bo He, Yue Xie, Liang Wen, Zhenguang Zhang, Xuejin Sun, Wei Zhao, Xiufeng Xu & Dan Han. (2017) Alternations of White Matter Structural Networks in First Episode Untreated Major Depressive Disorder with Short Duration. Frontiers in Psychiatry 8.
Crossref
Crossref
Keming Gao, Jennifer Sweet, Meilei Su & Joseph R. Calabrese. (2017) Depression severity and quality of life of qualified and unqualified patients with a mood disorder for a research study targeting anhedonia in a clinical sample. Asian Journal of Psychiatry 27, pages 40-47.
Crossref
Crossref
Chandni Sheth, Erin McGlade & Deborah Yurgelun-Todd. (2017) Chronic Stress in Adolescents and Its Neurobiological and Psychopathological Consequences: An RDoC Perspective. Chronic Stress 1, pages 247054701771564.
Crossref
Crossref